Search

everythinglearnresearchcommunity

for

Search:↓

Research 9 of 156

1. The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial Cancers · 2022 · 8 citations
2. Quality of Life of Patients with Metastatic Breast Cancer Treated with Epirubicin and Docetaxel International Journal of Clinical Medicine · 2011 · 4 citations
3. Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients Annals of Oncology · 2012 · 68 citations
4. Cooling-mediated protection from chemotherapy drug-induced cytotoxicity in human keratinocytes by inhibition of cellular drug uptake PLoS ONE · 2020 · 11 citations
5. Chemotherapy-induced alopecia: A novel observation Australasian Journal of Dermatology · 2018 · 2 citations
6. Abstract P3-09-15: Permanent chemotherapy induced alopecia in early breast cancer patients after (neo)adjuvant chemotherapy: Long term follow up Cancer Research · 2013 · 2 citations
7. Multiple drugs Reactions Weekly · 2017
8. Anthracycline analogs The past, present, and future Cancer Chemotherapy and Pharmacology · 1986 · 168 citations
9. Optimizing Scalp Cooling: (Ultra)Structural Follicular Characteristic and Restorative Advances Cancer Management and Research · 2025

Community

— no results